Linda Baddour has sold stock and made no open-market buys since Mar 2016

Linda Baddour is a corporate finance executive and board director with more than twenty years of experience in the healthcare, life sciences, and pharmaceutical sectors.( She has served as an Independent Director of Waters Corporation (NYSE: WAT) since 2018, where she brings deep strategic and financial expertise to the board of the global analytical laboratory instruments and software company.( In addition to her role at Waters, Baddour sits on the boards of CryoPort, Inc., Signant Health, and Flourish Research, and serves on Genstar Capital’s Strategic Advisory Board, advising the firm on healthcare investments.(

Prior to her board career, Baddour was Executive Vice President and Chief Financial Officer of PRA Health Sciences from 2007 to 2018, helping grow the global contract research organization from roughly 3,000 to more than 17,000 employees during her tenure.( Earlier, she held senior finance roles at Pharmaceutical Product Development, Inc. (PPD), including Chief Financial Officer, Treasurer, and Chief Accounting Officer, where she also led the company’s M&A and information technology strategies.( Baddour began her career in accounting and finance positions, including Controller at Cooperative Bank in Wilmington, North Carolina.( She earned both her BS in Accounting and MBA from the University of North Carolina at Wilmington and is a certified public accountant.(

Written by Perplexity from public sources.